Carrot Announces Agreement to Acquire GreenMan InSightVR, Expanding Eye Care’s Leading VR Diagnostics Platform Into Vision Simulation

The company that invented VR visual testing, now trusted in 2,500+ clinics for more than 6 million eye exams, will add immersive, interactive IOL simulation—bringing testing, diagnostics and simulation onto one platform

BROOKLYN, New York, October 09, 2026--Carrot (formerly Virtual Field), the most widely used VR testing and diagnostic platform in eye care, today announced an agreement to acquire GreenMan Vision, Inc., the company behind InSightVR. The deal will add intraocular lens (IOL) simulation for cataract surgery to the Carrot Platform and expand Carrot from vision diagnostics into vision simulation.

"For more than 40 years, patients have dreaded the visual field test," said Jeremy Barlow, CEO of Carrot. "It's long, tiring and hard to sit through, and it ties up rooms and staff. We asked ourselves a question: is this really the best we can do? Our answer was Carrot. We invented VR visual testing, created a category and changed eye care for good. GreenMan's founders asked a question of their own: why should anyone choose how they'll see for the rest of their life without experiencing it first? Their answer was InSightVR. Soon, both answers will live on the Carrot Platform. That's what we exist to do: push what's possible in eye care."

Since 2018, Carrot has been the standard everyone else is measured against. More doctors, clinical teams and patients use Carrot than any other VR visual testing headset. That includes more than 2,500 clinics, from independent practices to enterprise networks. In those clinics, Carrot isn't a headset in the corner. It's how testing gets done. Patients get a faster, more comfortable exam. AI/ML derived analysis and automation save technicians and doctors significant time on every exam — time they can give back to patients. And practices become more profitable.

Carrot's next platform evolution: vision simulation

Cataract surgery is one of the most commonly performed surgeries in the U.S., impacting millions of lives a year. At its center is a choice patients live with for life: which lens goes in their eye. Every option comes with tradeoffs, from glasses dependence to glare and halos. Yet most patients make that choice from a conversation and a brochure. They hear about their options. They never see them.

Cataract surgeons Michael Greenwood, MD, and Brandon Baartman, MD, of Vance Thompson Vision saw that gap in their own exam rooms and built InSightVR to close it. Using each patient's own biometry, InSightVR puts patients inside everyday scenes — from reading to night driving — where they can compare how every major lens type could change their vision.